Partnership for Glaucoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
University of Alabama at Birmingham
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00672048
First received: May 4, 2008
Last updated: December 20, 2012
Last verified: November 2012

May 4, 2008
December 20, 2012
October 2007
July 2013   (final data collection date for primary outcome measure)
To determine if innovative technology will improve process quality of care & important outcomes of care by optometrists in a cost-efficient manner while simultaneously empowering & including patients as part of the care process. [ Time Frame: Baseline, Year 1 and Year 2 ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00672048 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Partnership for Glaucoma
Expanding Quality Care for Glaucoma Through a Provider-Patient Partnership

The purpose of this study is to develop new ways of assisting patients with glaucoma and their eye doctors in using the recommendations from practice guidelines.

Glaucoma is a leading cause of blindness and visual impairment in the United States, particularly among disadvantaged populations. Despite the presence of therapies proven in NEI, randomized controlled trials that can be delivered by more than 18,000 ophthalmologists and 34,000 optometrists, almost nothing is known about the content and quality of glaucoma care delivered by non-MD providers such as optometrists. With the numbers of people with glaucoma expected to more than double in the next twenty years in the face of no more than a 15% increase in the supply of eye care providers, methods to better support appropriate and high-quality care for chronic eye diseases such as glaucoma delivered by optometrists will become as critical, if not more so, as techniques to enhance quality care among ophthalmologists.

Our study is a community-based, randomized, controlled trial that evaluates the suitability and effectiveness of a technology-based (tablet computer) intervention within the context of a novel partnership between optometrists and patients with glaucoma to improve the process quality of care and ultimately outcomes of care. By using successfully implemented technology in novel applications,and by building on the success of ongoing community-based quality improvement projects in our region, the study provides a means for rapid translation into community care if the intervention is successful.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Glaucoma
  • Other: Computer Tablet
    A tablet computer based software application designed to collect structured clinical information from providers and patients at the point of care.
  • Other: Continuing Education Course
    Annual standard continuing education
  • Other: Continuing education
    Annual standard continuing education materials
  • 1
    Interventions:
    • Other: Computer Tablet
    • Other: Continuing Education Course
  • 2
    Control group to receive annual continuing education
    Intervention: Other: Continuing education

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
1600
July 2013
July 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

-Diagnosis of open angle glaucoma with documented visual field loss.

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00672048
Pro00002593, R01EY018405-01
No
Duke University
Duke University
University of Alabama at Birmingham
Principal Investigator: Paul Lee, MD, JD Duke University
Duke University
November 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP